Skip to main content
. 2019 Feb 18;2019(2):CD012873. doi: 10.1002/14651858.CD012873.pub2
1 exp Anthracyclines/
2 anthracycline$.tw.
3 doxorubicin.tw.
4 epirubicin.tw.
5 daunorubicin.tw.
6 idarubicin.tw.
7 valrubicin.tw.
8 or/1‐7
9 exp Taxoids/
10 taxane$.tw.
11 docetaxel.tw.
12 paclitaxel.tw.
13 nab‐paclitaxel.tw.
14 Cabazitaxel.tw.
15 or/9‐14
16 8 and 15
17 randomized controlled trial.pt.
18 controlled clinical trial.pt.
19 randomized.ab.
20 placebo.ab.
21 Clinical Trials as Topic/
22 randomly.ab.
23 trial.ti.
24 (crossover or cross‐over).tw.
25 Pragmatic Clinical Trials as Topic/
26 pragmatic clinical trial.pt.
27 or/17‐26
28 exp Breast Neoplasms/
29 (breast adj6 cancer$).tw.
30 (breast adj6 neoplasm$).tw.
31 (breast adj6 carcinoma$).tw.
32 (breast adj6 tumo?r$).tw.
33 or/28‐32
34 16 and 27 and 33
35 remove duplicates from 34
36 Animals/ not Humans/
37 35 not 36